Brn-3c Inhibitors
Brn-3c (POU4F3) inhibitors consist of a range of compounds that reduces the expression and function of this transcription factor, primarily through indirect mechanisms affecting gene expression and DNA synthesis. Compounds like Retinoic Acid, Trichostatin A, and Suberoylanilide Hydroxamic Acid alter transcriptional regulation either by influencing transcription factor activity or by modifying chromatin structure. Such alterations can lead to a decrease in Brn-3c expression, highlighting the intricate regulation of transcription factors through epigenetic modifications.
Other compounds, including Fluorouracil, Doxorubicin, Cisplatin, Oxaliplatin, Camptothecin, and Hydroxyurea, inhibit DNA synthesis or cause DNA damage. These actions can indirectly inhibit Brn-3c expression by impeding the transcriptional processes essential for its production. Curcumin, with its broad effects on signaling pathways, can also impact Brn-3c expression through its influence on gene regulation. Additionally, Bortezomib, a proteasome inhibitor, can affect protein degradation pathways, influencing Brn-3c stability and expression. Rapamycin, an mTOR inhibitor, affects protein synthesis and cell growth, further contributing to the modulation of Brn-3c expression. These diverse mechanisms underscore the complex regulation of Brn-3c, reflecting the multifaceted nature of transcription factor regulation in cellular processes.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
A histone deacetylase inhibitor that can change chromatin structure, potentially leading to decreased expression of Brn-3c. | ||||||
Fluorouracil | 51-21-8 | sc-29060 sc-29060A | 1 g 5 g | $37.00 $152.00 | 11 | |
Inhibits thymidylate synthase, leading to a disruption in DNA synthesis. This disruption can indirectly reduce the expression of Brn-3c (POU4F3) by impairing the transcriptional machinery required for its production, as Brn-3c is a transcription factor reliant on active gene transcription. | ||||||
Doxorubicin | 23214-92-8 | sc-280681 sc-280681A | 1 mg 5 mg | $176.00 $426.00 | 43 | |
Induces DNA damage and can indirectly inhibit Brn-3c expression by affecting transcriptional regulation. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $133.00 $275.00 | 37 | |
Alters gene expression by inhibiting histone deacetylases, potentially leading to reduced Brn-3c expression. | ||||||
Cisplatin | 15663-27-1 | sc-200896 sc-200896A | 100 mg 500 mg | $138.00 $380.00 | 101 | |
Causes DNA cross-linking and damage, potentially reducing Brn-3c expression as a result of impaired transcription. | ||||||
Oxaliplatin | 61825-94-3 | sc-202270 sc-202270A | 5 mg 25 mg | $112.00 $394.00 | 8 | |
Similar to Cisplatin, causes DNA damage and can indirectly inhibit Brn-3c expression by affecting DNA transcription processes. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
As a proteasome inhibitor, Bortezomib affects protein degradation pathways. This can lead to an accumulation of proteins that regulate the stability and degradation of transcription factors like Brn-3c, indirectly resulting in reduced Brn-3c levels due to altered proteostasis and regulatory protein interactions. | ||||||
Camptothecin | 7689-03-4 | sc-200871 sc-200871A sc-200871B | 50 mg 250 mg 100 mg | $58.00 $186.00 $94.00 | 21 | |
Inhibits DNA topoisomerase I, potentially decreasing Brn-3c expression by impairing transcription. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
An mTOR inhibitor, Rapamycin affects protein synthesis and cell growth pathways. By inhibiting these pathways, Rapamycin can indirectly reduce Brn-3c expression. Since Brn-3c function is linked to cellular growth and proliferation processes, the inhibition of mTOR signaling can lead to decreased transcriptional activity of genes regulated by Brn-3c. | ||||||
Hydroxyurea | 127-07-1 | sc-29061 sc-29061A | 5 g 25 g | $78.00 $260.00 | 18 | |
Inhibits ribonucleotide reductase, potentially reducing DNA synthesis and indirectly affecting Brn-3c expression. | ||||||